Co-Authors
This is a "connection" page, showing publications co-authored by Frederick Hayden and Shunan Ruan.
Connection Strength
0.165
-
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020 May 24; 21(1):422.
Score: 0.055
-
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 05 16; 395(10236):1569-1578.
Score: 0.055
-
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 05 07; 382(19):1787-1799.
Score: 0.055